Breaking news – Pagina 95 – AMD

Breaking news

Febbraio 12, 2024 dario.olivero

Uric acid-lowering effects of sodium-glucose cotransporter 2 inhibitors for preventing cardiovascular events and mortality: A systematic review and meta-analysis

Diallo A, Diallo MF, Carlos-Bolumbu M, Galtier F
Diabetes Obes Metab. Pub. online 5 Feb 2024.

Leggi

Febbraio 9, 2024 dario.olivero

FDA MedWatch – Sustain and Schwinnng Dietary Supplement Capsules by Today The World Recall – Due to the Presence of Undeclared Tadalafil and Nortadalafil

05/02/2024

Leggi

Febbraio 12, 2024 dario.olivero

Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trial

Gilbert MP, Skelly J, Hernandez AF, et al.
Diabetes Obes Metab. Pub. online 6 Feb 2024.

Leggi

Febbraio 7, 2024 dario.olivero

Bringing an end to diabetes stigma and discrimination: an international consensus statement on evidence and recommendations

Speight J , Holmes-Truscott E, Garza M, et al.
Lancet Diabetes Endocrinol. 2024;12(1):61-82.

Leggi

Febbraio 6, 2024 dario.olivero

Efficacy and safety of tirzepatide in people with type 2 diabetes by baseline body mass index: An exploratory subgroup analysis of SURPASS-AP-Combo

Ma J,Liu M, Wang R, et al.
Diabetes Obes Metab. Pub. online 1 Feb 2024.

Leggi

Febbraio 6, 2024 dario.olivero

Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipidprofile for type 2 diabetes: Systematic review and network meta-analysis

Yao H, Zhang A, Li D, et al.
BMJ. Pub. online 29 Jan 2024.

Leggi

Febbraio 6, 2024 dario.olivero

Physical activity, gestational weight gain in obese patients with early gestational diabetes and the perinatal outcome – a randomised–controller trial

Adamczak L, Mantaj U, Sibiak R, et al.
BMC Pregnancy and Childbirth. Pub. online 2 Feb 2024.

Leggi

Febbraio 6, 2024 dario.olivero

Postprandial glucose-management strategies in type 1 diabetes: Current approaches and prospects with precision medicine and artificial intelligence

Jafar A, Pasqua MR
Diabetes Obes Metab. Pub. online 23 Jan 2024.

Leggi

Febbraio 6, 2024 dario.olivero

Glucagon secretion and its association with glycaemic control and ketogenesis during sodium-glucosecotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open-label, prospective study

Nakamura Y, Horie I, Kitamura T, et al.
Diabetes Obes Metab. Pub. online 23 Jan 2024.

Leggi

Febbraio 6, 2024 dario.olivero

Limitations of 14-day CGM sampling for assessment of hypoglycemia and glycemic variability in type 1 diabetes

Akturk HK
DiabetesTechnol Ther. Pub. online 1 Feb 2024.

Leggi